DexCom, Inc. (DXCM)
NASDAQ·Healthcare·Medical - Devices
$59.35
-3.35%
Mkt Cap $24.16B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 12, 2026 | $1.25B | $1.26B | +0.91% | $0.65 | $0.68 | +4.62% | — | — |
| Q4 2025 Oct 30, 2025 | $1.18B | $1.21B | +2.16% | $0.58 | $0.61 | +5.90% | — | — |
| Q3 2025 Jul 30, 2025 | $1.12B | $1.16B | +2.89% | $0.44 | $0.48 | +8.21% | — | — |
| Q2 2025 May 1, 2025 | $1.02B | $1.04B | +1.83% | $0.33 | $0.32 | -2.20% | — | — |
| Q1 2025 Feb 13, 2025 | $1.11B | $1.11B | +0.39% | $0.48 | $0.45 | -6.09% | — | — |
| Q4 2024 Oct 24, 2024 | $990.44M | $994.20M | +0.38% | $0.44 | $0.45 | +2.27% | — | — |
| Q3 2024 Jul 25, 2024 | $1.04B | $1.00B | -3.17% | $0.39 | $0.43 | +10.26% | — | — |
| Q2 2024 Apr 25, 2024 | $909.93M | $921.00M | +1.22% | $0.27 | $0.32 | +18.52% | — | — |
| Q1 2024 Feb 8, 2024 | $1.01B | $1.03B | +2.01% | $0.43 | $0.50 | +16.28% | — | — |
| Q4 2023 Oct 26, 2023 | $939.24M | $975.00M | +3.81% | $0.34 | $0.50 | +47.06% | — | — |
| Q3 2023 Jul 27, 2023 | $841.62M | $871.30M | +3.53% | $0.23 | $0.34 | +47.83% | — | — |
| Q2 2023 Apr 27, 2023 | $720.74M | $741.50M | +2.88% | $0.15 | $0.17 | +13.33% | — | — |
| Q1 2023 Feb 9, 2023 | $810.10M | $815.20M | +0.63% | $0.26 | $0.34 | +30.77% | — | — |
| Q4 2022 Oct 27, 2022 | $751.80M | $769.60M | +2.37% | $0.24 | $0.28 | +16.67% | — | — |
| Q3 2022 Jul 28, 2022 | $697.50M | $696.20M | -0.19% | $0.17 | $0.17 | +0.00% | — | — |
| Q2 2022 Apr 28, 2022 | $623.87M | $628.80M | +0.79% | $0.13 | $0.08 | -38.46% | — | — |
| Q1 2022 Feb 10, 2022 | $697.47M | $698.20M | +0.10% | $0.22 | $0.17 | -22.73% | — | — |
| Q4 2021 Oct 28, 2021 | $617.69M | $650.20M | +5.26% | $0.16 | $0.22 | +37.50% | — | — |
| Q3 2021 Jul 29, 2021 | $513.79M | $595.10M | +15.82% | $0.11 | $0.19 | +72.73% | — | — |
| Q2 2021 Apr 29, 2021 | $484.55M | $505.00M | +4.22% | $0.08 | $0.08 | +0.00% | — | — |